Mylan and King Terminate Merger
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 58 (Table of Contents)
Published: 5 Apr-2005
DOI: 10.3833/pdr.v2005.i58.701 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Mylan terminated the proposed acquisition of King Pharmaceuticals for US$4 B, as the two parties disagree upon the terms of the revised transaction...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS